As of March 31, 2024, Walpar Nutritions Ltd. carries a market capitalization of 955.93M, placing it among publicly traded companies globally. Its enterprise value stands at 1.06B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 955.93M |
| Enterprise Value | 1.06B |
As of March 31, 2024, Walpar Nutritions Ltd. has 9.08M shares outstanding.
| Shares Outstanding | 9.08M |
These figures are as of March 31, 2024.
| PB Ratio | 6.74 |
| P/TBV Ratio | 6.95 |
As of March 31, 2024, Walpar Nutritions Ltd. maintains a current ratio of 1.48, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.48 |
| Quick Ratio | 0.03 |
| Debt / Equity | 50.53 |
As of the close on October 13, 2026, Walpar Nutritions Ltd.'s stock has declined approximately 43.26% over the past 52 weeks. The 50-day moving average sits at 27.76, while the 200-day moving average is 40.11.
| 52-Week Price Change | -43.26% |
| 50-Day Moving Average | 27.76 |
| 200-Day Moving Average | 40.11 |
As of March 31, 2024, Walpar Nutritions Ltd. holds 5.06M in cash and equivalents against 82.99M in total debt, resulting in a net debt position of 77.93M. Total book value stands at 141.83M, with working capital of 79.67M providing operational flexibility.
| Cash & Cash Equivalents | 5.06M |
| Total Debt | 82.99M |
| Net Debt | 77.93M |
| Equity (Book Value) | 141.83M |
| Book Value Per Share | 15.62 |
| Working Capital | 79.67M |
Walpar Nutritions Ltd.'s most recent stock split took place on August 14, 2024 with a 1:2 split ratio.
| Last Split Date | 8/14/2024 |
| Split Ratio | 1:2 |
Already premium?